SCHEMBL3434869

SCHEMBL3434869

CC(C)C(NC(=O)c1cc(=O)[nH]c(=O)[nH]1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
ALDH1A1 P00352 1/20 0.50
CYP1A2 P05177 1/20 0.49
GPR84 Q9NQS5 4/20 0.47
CA2 P00918 3/20 0.40
CA1 P00915 2/20 0.40
AKR1B1 P15121 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3433136 0.86 GPR84 (0.49) LMNAALDH1A1CYP1A2GPR84CA2
SCHEMBL11979054 0.84 LMNA (0.53) LMNAALDH1A1CYP1A2GPR84CA2
SCHEMBL3360046 0.78 GRN (0.51) LMNAALDH1A1CYP1A2GPR84CA2
SCHEMBL21185729 0.75 ALDH1A1 (0.49) LMNAALDH1A1CYP1A2GPR84CA2
SCHEMBL16543122 0.73 CYP1A2 (0.61) LMNAALDH1A1CYP1A2GPR84CA1
SCHEMBL6446972 0.72 HSPA5 (0.60) LMNAALDH1A1GAAHPGDSMN1; SMN2
SCHEMBL28577021 0.72 KDM4E (0.47) LMNAALDH1A1CYP1A2GPR84CA2
SCHEMBL21185586 0.72 KDM4E (0.47) LMNAALDH1A1CYP1A2GPR84CA2
SCHEMBL6446970 0.72 HSPA5 (0.60) LMNAALDH1A1GAAHPGDSMN1; SMN2
Hydrochloric Acid SCHEMBL28578292 0.71 KDM4E (0.46) LMNAALDH1A1CYP1A2GPR84CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8236952-B2 Preparations containing amino acids and orotic acid Northern Innovations Holding Corp. (CA) 2012-08-07 US disclosed
US-8236952-B2 Preparations containing amino acids and orotic acid Northern Innovations Holding Corp. (CA) 2012-08-07 US disclosed
US-8236952-B2 Preparations containing amino acids and orotic acid Northern Innovations Holding Corp. (CA) 2012-08-07 US disclosed
EP-2231622-A1 PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID Northern Innovations and Formulations Corp. (CA) 2010-09-29 EP disclosed
WO-2009076743-A1 PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID IOVATE T. & P. INC. (CA) 2009-06-25 WO disclosed
WO-2009076743-A1 PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID IOVATE T. & P. INC. (CA) 2009-06-25 WO disclosed
US-20090156812-A1 PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID IOVATE T. & P. INC. (CA) 2009-06-18 US disclosed
US-20090156812-A1 PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID IOVATE T. & P. INC. (CA) 2009-06-18 US disclosed
US-20090156812-A1 PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID IOVATE T. & P. INC. (CA) 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156812-A1 PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID DDC, ODC1, OTC LMNA 4516/4885ALDH1A1 2765/4885CYP1A2 3272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.